Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
Published June 4, 2020
N Engl J Med 2020;382:2582
DOI: 10.1056/NEJMc2021225
To the Editor: Because all the authors were not granted access to the raw data and the raw data could not be made available to a third-party auditor, we are unable to validate the primary data sources underlying our article, “Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19.”1 We therefore request that the article be retracted. We apologize to the editors and to readers of the Journal for the difficulties that this has caused.
Notes
This letter was published on June 4, 2020, at NEJM.org.
Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.
Supplementary Material
Disclosure Forms (nejmc2021225_disclosures.pdf)
- Download
- 191.25 KB
Reference
1.
Mehra MR, Desai SS, Kuy S, Henry TD, Patel AN. Cardiovascular disease, drug therapy, and mortality in Covid-19. N Engl J Med 2020;382:e102-e102.
Information & Authors
Information
Published In
Copyright
Copyright © 2020 Massachusetts Medical Society. All rights reserved.
For personal use only. Any commercial reuse of NEJM Group content requires permission.
History
Published online: June 4, 2020
Published in issue: June 25, 2020
Authors
Affiliations
1Brigham and Women’s Hospital Heart and Vascular Center, Boston, MA
[email protected]
[email protected]
2Surgisphere, Chicago, IL
3Baylor College of Medicine, Houston, TX
4Christ Hospital, Cincinnati, OH
5University of Utah, Salt Lake City, UT
Metrics & Citations
Metrics
Altmetrics
Citations
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Scientific Accountability: Detecting Salient Features of Retracted Articles, Proceedings of the 17th ACM Web Science Conference 2025, (75-85), (2025).https://doi.org/10.1145/3717867.3717885
- The Need for Prospective Integrity Standards for the Use of Generative AI in Research, Journal of Law, Medicine & Ethics, (1-6), (2025).https://doi.org/10.1017/jme.2025.41
- Historiography of Scientific Publishing across Cultures and Disciplines, Indian Journal of Radiology and Imaging, 35, S 01, (S2-S8), (2025).https://doi.org/10.1055/s-0044-1800865
- Precision medicine in cardiovascular disease, Implementation of Personalized Precision Medicine, (241-254), (2025).https://doi.org/10.1016/B978-0-323-98808-7.00014-X
- When I use a word . . . Academic felonies and misdemeanours—adverse effects, BMJ, (q2787), (2024).https://doi.org/10.1136/bmj.q2787
- Auditing citation polarization during the early COVID-19 pandemic, Quantitative Science Studies, 5, 4, (906-921), (2024).https://doi.org/10.1162/qss_a_00326
- Publishing the pandemic: the impact of COVID-19 on science and scientific publishing, COVID-19: An Update, (2024).https://doi.org/10.1183/2312508X.10021623
- A predictive model to explore risk factors for severe COVID-19, Scientific Reports, 14, 1, (2024).https://doi.org/10.1038/s41598-024-68946-y
- Burden of cardiovascular disease on coronavirus disease 2019 hospitalizations in the USA, Coronary Artery Disease, 35, 7, (584-589), (2024).https://doi.org/10.1097/MCA.0000000000001390
- Wearable biosensors for cardiovascular monitoring leveraging nanomaterials, Advanced Composites and Hybrid Materials, 7, 3, (2024).https://doi.org/10.1007/s42114-024-00906-6
- See more
Loading...